Eugenia Nnenna Nnedinma Uche-Anya, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gallstones | 2 | 2024 | 283 | 1.560 |
Why?
|
| Gastroenterology | 2 | 2023 | 571 | 1.080 |
Why?
|
| Celiac Disease | 2 | 2021 | 822 | 0.870 |
Why?
|
| Colonoscopy | 2 | 2020 | 1388 | 0.770 |
Why?
|
| Privacy | 1 | 2023 | 233 | 0.760 |
Why?
|
| Pancreaticojejunostomy | 1 | 2017 | 26 | 0.600 |
Why?
|
| Microvilli | 1 | 2017 | 233 | 0.570 |
Why?
|
| Duodenal Diseases | 1 | 2017 | 99 | 0.570 |
Why?
|
| Endosonography | 2 | 2017 | 607 | 0.550 |
Why?
|
| Pancreatic Ducts | 1 | 2017 | 329 | 0.520 |
Why?
|
| Metabolomics | 1 | 2024 | 1629 | 0.490 |
Why?
|
| Prescriptions | 1 | 2017 | 387 | 0.490 |
Why?
|
| Choristoma | 1 | 2016 | 207 | 0.470 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 1097 | 0.460 |
Why?
|
| Benchmarking | 1 | 2020 | 1042 | 0.440 |
Why?
|
| Catheterization | 1 | 2017 | 1426 | 0.410 |
Why?
|
| Tetrazoles | 1 | 2017 | 899 | 0.390 |
Why?
|
| Imidazoles | 1 | 2017 | 1179 | 0.380 |
Why?
|
| Carcinoma in Situ | 1 | 2016 | 796 | 0.360 |
Why?
|
| Colorectal Neoplasms | 2 | 2020 | 6852 | 0.340 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 1797 | 0.340 |
Why?
|
| Pancreas | 1 | 2016 | 1676 | 0.330 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 2018 | 0.300 |
Why?
|
| New York City | 2 | 2020 | 725 | 0.290 |
Why?
|
| Stomach Neoplasms | 1 | 2016 | 1422 | 0.260 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 3211 | 0.250 |
Why?
|
| Quality Improvement | 1 | 2020 | 3806 | 0.240 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2023 | 867 | 0.230 |
Why?
|
| Food Handling | 1 | 2024 | 155 | 0.230 |
Why?
|
| Fast Foods | 1 | 2024 | 210 | 0.200 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 6313 | 0.200 |
Why?
|
| Chromatography, Liquid | 1 | 2024 | 986 | 0.180 |
Why?
|
| Confidentiality | 1 | 2023 | 609 | 0.160 |
Why?
|
| Glutens | 1 | 2021 | 240 | 0.160 |
Why?
|
| Diet, Gluten-Free | 1 | 2021 | 280 | 0.160 |
Why?
|
| Nesidioblastosis | 1 | 2017 | 4 | 0.150 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2024 | 1186 | 0.150 |
Why?
|
| Fatty Liver | 1 | 2024 | 777 | 0.150 |
Why?
|
| Gastrointestinal Tract | 1 | 2023 | 830 | 0.150 |
Why?
|
| Triglycerides | 1 | 2024 | 2450 | 0.140 |
Why?
|
| Incidence | 2 | 2024 | 21273 | 0.130 |
Why?
|
| Postoperative Complications | 1 | 2017 | 15638 | 0.120 |
Why?
|
| Natural Language Processing | 1 | 2024 | 1135 | 0.120 |
Why?
|
| Postoperative Period | 1 | 2019 | 1812 | 0.120 |
Why?
|
| Registries | 2 | 2021 | 8176 | 0.120 |
Why?
|
| Medical Records | 1 | 2019 | 1406 | 0.110 |
Why?
|
| Endoscopy | 1 | 2023 | 1834 | 0.110 |
Why?
|
| Humans | 14 | 2024 | 758381 | 0.100 |
Why?
|
| Adult | 6 | 2024 | 219916 | 0.100 |
Why?
|
| Risk Factors | 3 | 2024 | 73806 | 0.100 |
Why?
|
| Middle Aged | 5 | 2024 | 219560 | 0.090 |
Why?
|
| United States | 3 | 2024 | 72140 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2024 | 54136 | 0.080 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 12440 | 0.080 |
Why?
|
| Male | 6 | 2024 | 358742 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 2551 | 0.070 |
Why?
|
| Diet | 1 | 2024 | 8003 | 0.070 |
Why?
|
| Myocytes, Cardiac | 1 | 2015 | 1655 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2021 | 7980 | 0.060 |
Why?
|
| Female | 5 | 2024 | 390316 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2015 | 2248 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2020 | 4775 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3362 | 0.060 |
Why?
|
| Aged | 3 | 2024 | 168217 | 0.060 |
Why?
|
| Liver Cirrhosis | 2 | 2024 | 1930 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 58681 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 1842 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 39060 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2024 | 41252 | 0.050 |
Why?
|
| Prevalence | 1 | 2017 | 15646 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 12076 | 0.040 |
Why?
|
| Time Factors | 1 | 2019 | 39873 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2015 | 11471 | 0.040 |
Why?
|
| Syndactyly | 1 | 2015 | 72 | 0.030 |
Why?
|
| Child | 1 | 2021 | 79813 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 835 | 0.030 |
Why?
|
| Biopsy | 1 | 2024 | 6768 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2015 | 790 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 58808 | 0.020 |
Why?
|
| Long QT Syndrome | 1 | 2015 | 465 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 87888 | 0.020 |
Why?
|
| Action Potentials | 1 | 2015 | 1816 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 3734 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2015 | 1216 | 0.020 |
Why?
|
| Algorithms | 1 | 2024 | 13959 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 25953 | 0.010 |
Why?
|
| Calcium | 1 | 2015 | 5721 | 0.010 |
Why?
|
| Phenotype | 1 | 2015 | 16534 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 80170 | 0.010 |
Why?
|